Company intelligence / Profile preview

Meru Health

San Mateo, California, United Statesmeruhealth.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Peer-reviewed clinical trials have shown significant reductions in depression symptoms with high program completion rates (~80%). Two-year longitudinal results demonstrate sustained treatment gains. The program has been found to be more effective than traditional therapy for many users.

Therapeutic areas: Psychiatry
Modalities: Digital therapeutic programNon-pharmacological therapyDevice (biofeedback wearable)
Industry: Digital Health Medical Devices

Partnerships

Stanford UniversityCurebaseMINES & Associates

Beyond the preview

Go deeper on Meru Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meru Health.

Explore the full profile